2nd Strategic Partnerships for Drug Repurposing Forum - Hyatt Regency Boston Harbor

2nd Strategic Partnerships for Drug Repurposing Forum
October 26 - 27, 2017
Hyatt Regency Boston Harbor
Boston, MA

Understand the importance of drug repurposing, repositioning and rescue through innovative strategies

2nd Strategic Partnerships for Drug Repurposing Forum – 2nd Strategic Partnerships for Drug Repurposing Forum

Drug repurposing, repositioning and rescue all allow pharmaceutical companies to maintain or increase the life cycle of drugs and decrease the expense of the full research and development process. Typically these drugs are either approved and marketed compounds used daily in a clinical setting, or drugs that have been “shelved.” These techniques are often used in the area of rare and orphan diseases since there is no incentive to formulate new drugs for small patient populations.

The 2nd Strategic Partnerships for Drug Repurposing Forum will showcase the importance of drug repurposing, repositioning and rescue through innovative strategies.  Attendees will learn about the different resources available to them, including public-private partnerships, foundations, patient advocacy groups, universities and other funding partners. We will highlight new innovations and explore methods for navigating regulations.

 Top Five Reasons to Attend

  1. Understand the methods to effectively redevelop an existing or failed drug
  2. Explore how to develop strategic partnerships between the government, universities, patient advocacy groups, foundations and sponsors
  3. Learn from cases studies on repurposing efforts and new perspectives on repurposing
  4. Discuss the key challenges in partnerships and how the field is approaching the repurposing idea
  5. Understand the FDA regulations (505b) for New Drug Applications, the legal framework and intellectual property laws surrounding drug repurposing

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotechnology and medical device organizations; patient organizations; and nonprofit foundations with responsibilities in the following areas:

  • Drug Repurposing
  • Indication Expansion
  • Strategic Partnerships and Alliances
  • Global Commercialization/Strategy
  • Program and Portfolio Development
  • Translational Medicine
  • Strategy and Portfolio Solutions
  • Corporate Strategy
  • Market Access
  • Asset Management
  • Advanced Brand Strategies
  • Research and Development
  • Scientific/Clinical Development
  • Regulatory Affairs
  • Bioinformatics
  • Big Data Analytics
  • Patient Networks

This event is also of interest to professionals involved in:

    • Clinical Operations/Clinical Outsourcing
    • Trauma Therapeutics

Drug Delivery/Discovery

  • Product Development
  • Clinical Operations
live chat software